[dreamcompiler]

> Big pharma won’t give a shit because Mark can’t make his own generic versions due to IP.

Of course there's no IP protection; that's the definition of "generic." But that doesn't mean big pharma won't care. 20 years ago they might not have cared. Nowadays big pharma has learned how to game the generics industry to become sole-source generic providers and set prices as high as they wish, even without IP protection. It's this abuse of the generic marketplace that Cuban seems to be taking on.